X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RYTM

Closed

Rhythm Pharmaceuticals Inc

65.44
+2.25 (+3.56%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 63.19
Day's Range: 62.835 - 66.21
Send
When Written:
 
18.09
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company that specializes in the development and commercialization of therapies for rare genetic diseases of obesity. The company was founded in 2008 and is headquartered in Boston, Massachusetts. Rhythm's lead product candidate, setmelanotide, is a first-in-class melanocortin-4 receptor (MC4R) agonist being developed for the treatment of rare genetic disorders of obesity, including Bardet-Biedl syndrome (BBS) and Alström syndrome, as well as other MC4R-related obesity disorders. The company's mission is to improve the lives of people living with rare genetic disorders of obesity by developing and delivering innovative therapies. Rhythm is committed to advancing the understanding of the genetic causes of obesity and to developing treatments that address the underlying biology of these disorders.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X